Instructions
Please read this page carefully. You will need to scroll down this page and ensure that you have read the learning objectives, accreditation information, and potential conflicts of interest disclosures for the authoring faculty. Please check the box to agree to the terms of understanding and click the "Start Module" button on the bottom of the page to begin your learning activity.

Learning Objectives
After completing this educational activity, the learner should be better able to:

• Identify challenges related to determining an optimal continuum of care for patients with advanced stage rectal cancer
• Discuss current and emerging treatments for patients with stage III rectal cancer
• Distinguish between treatment options for synchronous metastatic rectal cancer versus metasynchronous metastatic rectal cancer
• Develop an appropriate management regimen for patients with locally advanced rectal cancer with synchronous low volume metastatic disease based on pathologic staging and treatment history
• Explain the issues that complicate the lines of treatment for patients with previously untreated metastatic rectal cancer
• Identify new therapies available for those with advanced metastatic rectal cancer and determine patient eligibility based on type and timing of previous therapies

Accreditation
This learning activity has expired however you may still review module content.

Target Audience
This learning activity is intended for a broad audience of healthcare practitioners, including medical oncologists, primary care physicians, family physicians, specialists, nurse practitioners, and physician assistants.

Disclosure Statements
To view the Disclosure Statements, please click here.